Congrats to @BrownUniversity senior undergrad student & #eldeirylab member Brooke Verschleiser on winning the Llealyn B. Clapp Prize for Outstanding Undergraduate Thesis from the Chemistry Department. She presented research at #AACR23 & published paper https://pubmed.ncbi.nlm.nih.gov/37559992/
Pan-integrin inhibitor GLPG-0187 promotes T-cell killing of mismatch repair-deficient colorectal cancer cells by suppression of SMAD/TGF-β signaling - PubMed

Colorectal cancer is the third leading cause of cancer-related death and the third most common cause of cancer. As the five-year survival with advanced metastatic colorectal cancer (mCRC) is 14%, new treatment strategies are needed. Immune checkpoint blockade, which takes advantage of an individual' …

PubMed
The biomedical research ecosystem in the US needs investments to maintain excellence and to continue to make breakthrough discoveries. In 2 short years, we have gone from the most abstracts in the world at #AACR23 to not attending in person for #AACR25 https://x.com/weldeiry/status/1639635531142160384
Wafik S. El-Deiry, MD, PhD, FACP (@weldeiry) on X

Excited, proud and looking forward to the 65 #AACR23 #AACR2023 presentations by colleagues from the Legorreta Cancer Center @BrownUCancer reflecting many collaborations internal and external (1% of AACR abstracts from the whole world)-they include 43 from #eldeirylab group which

X (formerly Twitter)
The biomedical research ecosystem in the US needs investments to maintain excellence and to continue to make breakthrough discoveries. In 2 short years, we have gone from the most abstracts in the world at #AACR23 to not attending in person for #AACR25 https://x.com/weldeiry/status/1639635531142160384
Wafik S. El-Deiry, MD, PhD, FACP (@weldeiry) on X

Excited, proud and looking forward to the 65 #AACR23 #AACR2023 presentations by colleagues from the Legorreta Cancer Center @BrownUCancer reflecting many collaborations internal and external (1% of AACR abstracts from the whole world)-they include 43 from #eldeirylab group which

X (formerly Twitter)

Looking forward to the largest scientific gathering on cancer research in the world AACR24 @AACR meeting in San Diego on April 5-10, 2024.

This should be a great meeting for learning, networking, & catching up with colleagues & friends from around the world. I'm also looking forward to our 33 presentations from #eldeirylab at #LegorretaCancerCenter & many others from @BrownUCancer (33 abstracts from the #eldeirylab is above average for us but a few less than career high of 43 at #AACR23)

This is where the posters I presented this year at #AACR23 and #ASCO23 have ended up for now @BrownUCancer @BrownMedicine @BrownUniversity @BrownOncology @BrownPathology @BrownUPathoGP

Stock drama, cancer vaccine success, and new science — highlights from AACR #AACR23

https://apple.news/Ar3JRGhY1QuicH3Forp-KTg

Stock drama, cancer vaccine success, and new science — highlights from AACR — STAT

ORLANDO, Fla. — There was some drama at the American Association for Cancer Research annual meeting: stocks crashed, companies debuted new compounds and trial results, and a blood cancer mystery inched closer to being solved. If you missed the conference here this past week, here are some highlights.

Quite a few @BrownUniversity undergraduate, medical, masters and PhD level graduate students descended to Orlando and presented their research at @BrownUCancer @BrownMedicine at the @AACR #AACR23 meeting.

Here are some of them 👇

Scholar, researcher, and musician, William MacDonald is a @BrownUniversity senior student who presented his novel results @BrownUCancer at the #AACR23 #AACR2023 meeting in Orlando. #eldeirylab @BrownMedicine
Researchers report on promising novel antitumor strategies in early-phase clinical trials - AACR Annual Meeting News

During the Annual Meeting’s third clinical trials plenary session, researchers reported promising results from four early-phase trials. Samer A. Srour, MD, reported results from the first-in-human trial of allogeneic CAR T therapy targeting CD70 expressed in metastatic renal cell carcinoma.

AACR Annual Meeting News

NCI Director @NCIDirector discusses Cancer Moonshot initiative and new National Cancer Plan
#AACR23

https://www.aacrmeetingnews.org/news/nci-director-discusses-cancer-moonshot-initiative-and-new-national-cancer-plan/

NCI Director discusses Cancer Moonshot initiative and new National Cancer Plan - AACR Annual Meeting News

During a unique Annual Meeting session Monday morning, National Cancer Institute Director Monica M. Bertagnolli, MD (pictured), sat down with AACR President Lisa M. Coussens, PhD, FAACR, to discuss the NCI’s goals for the Cancer Moonshot initiative and the recently released National Cancer Plan.

AACR Annual Meeting News